Related Experiment Video

Updated: Jun 22, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Pathogenesis of lung cancer signalling pathways: roadmap for therapies

E Brambilla1, A Gazdar

  • 1Dept of Pathology, Institut Albert Bonniot, INSERM U823, University Joseph Fourier, CHRU Grenoble Hôpital Michallon, Grenoble, France. ebrambilla@chu-grenoble.fr

The European Respiratory Journal
|June 2, 2009
PubMed

Insights

Lung cancer remains a leading cause of cancer death, necessitating novel therapies. Understanding genetic and epigenetic pathways offers new avenues for targeted lung cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a leading global cancer killer with poor survival rates, highlighting the urgent need for improved therapeutic strategies.
  • Advances in understanding lung cancer biology are paving the way for personalized treatments targeting specific genes and molecular pathways.
  • Key signaling pathways implicated in lung cancer include growth promotion (EGFR/Ras/PI3K), growth inhibition (p53/Rb/p14ARF, STK11), apoptosis (Bcl-2/Bax/Fas/FasL), DNA repair, and immortalization.

Purpose of the Study:

  • To review the critical genetic and epigenetic pathways involved in lung tumorigenesis.
  • To explore how these pathways can inform the development of targeted therapies for lung cancer.
  • To differentiate the molecular mechanisms between smokers and non-smokers.

Main Methods:

  • Review of current literature on lung cancer genetics and epigenetics.
  • Analysis of key signaling pathways implicated in tumor development and progression.
  • Examination of epigenetic modifications such as DNA methylation, histone modification, and micro-RNA in lung cancer.

Main Results:

  • Genetic and epigenetic alterations significantly contribute to lung cancer development by modifying gene expression and chromatin structure.
  • Epigenetic changes, including DNA methylation and micro-RNA dysregulation, silence tumor suppressor genes and activate oncogenes.
  • Distinct genetic and epigenetic pathways are observed in smokers versus non-smokers, offering potential for differential therapeutic approaches.

Conclusions:

  • Targeting specific genetic and epigenetic pathways holds promise for developing customized and more effective lung cancer therapies.
  • Understanding these molecular pathways is crucial for improving cancer diagnosis, prognosis, and clinical management.
  • The distinct molecular profiles in smokers and non-smokers underscore the need for tailored treatment strategies in lung cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...